Reference page — cumulative record through Thursday, October 8, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Concert
Product reference — Concert by Ibm · sector: Enterprise Applications. Cumulative disclosure record for this product across the archive.
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 18 | 18 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 6.3 | .0022 | 4 | 3 | 11 | 0 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): ▂█▁
| Month | New CVEs |
|---|---|
| 2026-08 | 2 |
| 2026-09 | 16 |
| 2026-10 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-6721 | 9.8 | 72.5 | CRITICAL | — | 2026-09-23 |
| CVE-2026-3627 | 9.1 | 41.7 | CRITICAL | — | 2026-08-28 |
| CVE-2026-6928 | 9.8 | 37.1 | CRITICAL | — | 2026-09-23 |
| CVE-2025-12767 | 5.3 | 27.3 | MEDIUM | — | 2026-09-22 |
| CVE-2026-6925 | 5.3 | 23.6 | MEDIUM | — | 2026-09-23 |
| CVE-2026-6730 | 7.8 | 21.2 | HIGH | — | 2026-09-23 |
| CVE-2026-17472 | 9.6 | 21.0 | CRITICAL | — | 2026-09-22 |
| CVE-2026-17465 | 6.5 | 18.7 | MEDIUM | — | 2026-09-22 |
| CVE-2026-3626 | 5.3 | 13.9 | MEDIUM | — | 2026-09-23 |
| CVE-2026-16426 | 6.5 | 8.3 | MEDIUM | — | 2026-09-22 |
| CVE-2026-6327 | 4.3 | 5.7 | MEDIUM | — | 2026-09-23 |
| CVE-2025-64649 | 5.9 | 5.5 | MEDIUM | — | 2026-08-28 |
| CVE-2025-36084 | 5.9 | 4.8 | MEDIUM | — | 2026-09-22 |
| CVE-2026-15915 | 6.2 | 1.8 | MEDIUM | — | 2026-09-22 |
| CVE-2026-6935 | 7.8 | 1.6 | HIGH | — | 2026-09-23 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-6544 | 6.2 | 1.6 | MEDIUM | — | 2026-09-24 |
| CVE-2026-6935 | 7.8 | 1.6 | HIGH | — | 2026-09-23 |
| CVE-2026-6928 | 9.8 | 37.1 | CRITICAL | — | 2026-09-23 |
| CVE-2026-6794 | 7.8 | 1.3 | HIGH | — | 2026-09-23 |
| CVE-2026-6730 | 7.8 | 21.2 | HIGH | — | 2026-09-23 |
| CVE-2026-6721 | 9.8 | 72.5 | CRITICAL | — | 2026-09-23 |
| CVE-2026-6925 | 5.3 | 23.6 | MEDIUM | — | 2026-09-23 |
| CVE-2026-6718 | 6.2 | 0.9 | MEDIUM | — | 2026-09-23 |
| CVE-2026-6327 | 4.3 | 5.7 | MEDIUM | — | 2026-09-23 |
| CVE-2026-3626 | 5.3 | 13.9 | MEDIUM | — | 2026-09-23 |
| CVE-2026-17472 | 9.6 | 21.0 | CRITICAL | — | 2026-09-22 |
| CVE-2026-16426 | 6.5 | 8.3 | MEDIUM | — | 2026-09-22 |
| CVE-2025-12767 | 5.3 | 27.3 | MEDIUM | — | 2026-09-22 |
| CVE-2026-17465 | 6.5 | 18.7 | MEDIUM | — | 2026-09-22 |
| CVE-2025-36084 | 5.9 | 4.8 | MEDIUM | — | 2026-09-22 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Ibm — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.